![Foto de Teresa](/img/nophoto.png)
Teresa
Lozano Moreda
Profesional Investigadora
Argitalpenak (51) Teresa Lozano Moreda argitalpenak
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2023
-
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma
Molecular Therapy, Vol. 31, Núm. 1, pp. 48-65
-
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses
Cancer Letters, Vol. 561
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
-
The transcriptional regulator Sin3A balances IL-17A and Foxp3 expression in primary CD4 T cells
EMBO Reports, Vol. 24, Núm. 5
2022
-
BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis
Journal of Experimental Medicine, Vol. 219, Núm. 12
-
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Science Advances, Vol. 8, Núm. 39
-
Impact of tumor microenvironment on adoptive T cell transfer activity
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 1-31
-
Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer
Molecular Therapy - Nucleic Acids, Vol. 29, pp. 387-399
-
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
OncoImmunology, Vol. 11, Núm. 1
-
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
Cancer Letters, Vol. 528, pp. 45-58
-
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1
-
Enhanced recovery after low- and medium-risk liver transplantation. A single-center prospective observational cohort study
International Journal of Surgery, Vol. 85, pp. 46-54
-
Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma
BioMed Research International, Vol. 2021
-
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3
-
Searching for peptide inhibitors of t regulatory cell activity by targeting specific domains of foxp3 transcription factor
Biomedicines, Vol. 9, Núm. 2, pp. 1-20
2020
-
A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2
Scientific Reports, Vol. 10, Núm. 1
-
A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells
Nature, Vol. 583, Núm. 7816, pp. 447-452